In the past few weeks, more information has come to the public’s attention as C.R. Bard IVC filters were featured in a two-part NBC Nightly News segment. The year-long investigation raises more serious questions about why medical device manufacturer C.R. Bard continued to sell and market its inferior vena cava (IVC) filters even after the company became aware that its filters were failing and causing death and other serious injuries at significantly high rates. The investigation alone revealed 27 deaths and more than 300 injuries related to the Bard Recovery model IVC filter. The people and injuries featured in this story are real. Their lives were affected in real ways, the same as many others might have been as well. If you are one of those people, please contact our office immediately to see how we might be able to help – (800) 269-3050.
Medical Device to Stop Blood Clots Associated With 27 Fatalities
Did Manufacturer of Medical Device Linked to 27 Deaths Ignore Safety Concerns?
By Shelley Blas
May 18, 2012 – A new study, published earlier this week in the British Medical Journal shows that NuvaRing carries a higher risk of blood clots than combined oral contraceptives (COCs) based on oestrogens and progestins. Women who used the vaginal ring or transdermal patches had around a 6- to 8 fold increased risk of venous thromboembolism compared with women who used no hormonal contraception.
The NuvaRing is a small and flexible vaginal ring introduced by Merck & Co. in 2001 as a once a-month contraceptive. NuvaRing uses a high dose of what is known as a third generation progestin, which has been linked to deadly blood clots. In 2007, Public Citizen petitioned the FDA to ban oral birth control pills that contain this third generation hormone since it was shown to double the risk of blood clots when compared to second generation oral contraceptives. The Nations Law Firm has represented women across the country for their injuries resulting from the Ortho Evra patch and the Yaz/Yasmin birth control pills. We are currently reviewing NuvaRing cases. Please contact our offices for a free case evaluation with one of our experienced attorneys.